Micheal Tachezy
Priv.-Doz. Dr. med.
Micheal Tachezy
MBA
  • Funktionsoberarzt
  • Facharzt für Viszeralchirurgie
  • Spezielle Viszeralchirurgie
Arbeitsbereich

Standort

Hauptgebäude O10 , 2. Etage
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Publikationen

Zurück
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
Vor

Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma
Jacobsen F, Kohsar J, Gebauer F, Kluth M, Hube-Magg C, Simon R, Bockhorn M, Hinsch A, Burandt E, Lübke A, Steurer S, Tachezy M, Sauter G, Izbicki J, Wilczak W, Melling N
ONCOTARGET. 2020;11(12):1007-1016.

Improved colorectal anastomotic leakage healing by transanal rinsing treatment after endoscopic vacuum therapy using a novel patient-applied rinsing catheter
Kantowski M, Kunze A, Bellon E, Rösch T, Settmacher U, Tachezy M
INT J COLORECTAL DIS. 2020;35(1):109-117.

Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power
Karstens K, Bellon E, Polonski A, Wolters-Eisfeld G, Melling N, Reeh M, Izbicki J, Tachezy M
ONCOTARGET. 2020;11(13):1131-1140.

Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas
Karstens K, Ghadban T, Sawez S, Konczalla L, Woestemeier A, Bachmann K, Uzunoglu F, Tachezy M, Vettorazzi E, Izbicki J, Reeh M
EJSO-EUR J SURG ONC. 2020;46(4 Pt A):638-643.

Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas
Karstens K, Kempski J, Giannou A, Freiwald E, Reeh M, Tachezy M, Izbicki J, Lohse A, Gagliani N, Huber S, Pelczar P
PLOS ONE. 2020;15(4):e0231833.

Endoscopic vacuum therapy versus stenting for postoperative esophago-enteric anastomotic leakage: systematic review and meta-analysis
Scognamiglio P, Reeh M, Karstens K, Bellon E, Kantowski M, Schön G, Zapf A, Chon S, Izbicki J, Tachezy M
ENDOSCOPY. 2020 [Epub ahead of print].

Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC)
Hötzel J, Melling N, Müller J, Polonski A, Wolters-Eisfeld G, Izbicki J, Karstens K, Tachezy M
J CANCER RES CLIN. 2019;145(9):2285-2292.

Surgical Management of Non-Malignant Esophageal Perforations: A Single-Center Analysis Over a 15-Year Period
Karstens K, Bellon E, Tachezy M, Izbicki J, Ghadban T, Duprée A, Uzunoglu F, Bachmann K, Koenig A, Reeh M
DIGEST SURG. 2019 [Epub ahead of print].

p53 overexpression is a prognosticator of poor outcome in esophageal cancer
Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F
ONCOL LETT. 2019;17(4):3826-3834.

A hairy cavity: endoscopic therapy of a presacral recurrence of a complex pilonidal sinus
Noorah A, Bellon E, Izbicki J, Tachezy M, Kantowski M
INT J COLORECTAL DIS. 2019;34(10):1791-1794.

Evidenz für chirurgische Standardverfahren: Appendizitis, Divertikulitis und Cholezystitis
Tachezy M, Izbicki J
CHIRURG. 2019;90(5):351-356.

Palliative Chirurgie
Tachezy M, Karstens K, Izbicki J
J Onkol - Z Onkol Fortb. 2019;2019(7):.

CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
Wachowiak R, Mayer S, Suttkus A, Martynov I, Lacher M, Melling N, Izbicki J, Tachezy M
OPEN MED-WARSAW. 2019;14:920-927.

Improved risk stratification by circulating tumor cell counts in pancreatic cancer
Effenberger K, Schroeder C, Hanssen A, Wolter S, Eulenburg C, Tachezy M, Gebauer F, Izbicki J, Pantel K, Bockhorn M
CLIN CANCER RES. 2018;24(12):2844-2850.

Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
Yang S, Che S, Kurywchak P, Tavormina J, Gansmo L, Correa de Sampaio P, Tachezy M, Bockhorn M, Gebauer F, Haltom A, Melo S, LeBleu V, Kalluri R
CANCER BIOL THER. 2017;18(3):158-165.

Pancreatic cancer and liver metastases: state of the art
Bellon E, Gebauer F, Tachezy M, Izbicki J, Bockhorn M
Updates Surg. 2016;68(3):247-251.

Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
Gebauer F, Gelis S, Zander H, Meyer K, Wolters-Eisfeld G, Izbicki J, Bockhorn M, Tachezy M
ONCOTARGET. 2016;7(15):20945-52.

Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis
Gebauer F, Wicklein D, Tachezy M, Grob T, Steinemann D, Manukjan G, Göhring G, Schlegelberger B, Maar H, Izbicki J, Bockhorn M, Schumacher U
ANTICANCER RES. 2016;36(4):1507-18.

Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment
Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu F, Vashist Y, Izbicki J, Bogoevski D
SURGERY. 2016;159(6):1548-56.

Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis
Tachezy M, Gebauer F, Janot M, Uhl W, Zerbi A, Montorsi M, Perinel J, Adham M, Dervenis C, Agalianos C, Malleo G, Maggino L, Stein A, Izbicki J, Bockhorn M
SURGERY. 2016;160(1):136-44.

Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma
Wachowiak R, Mayer S, Kaifi J, Gebauer F, Izbicki J, Lacher M, Bockhorn M, Tachezy M
ANTICANCER RES. 2016;36(8):3991-5.

Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
Gebauer F, Tachezy M, Vashist Y, Marx A, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(2):493-9.

Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)
Clauditz T, von Rheinbaben K, Lebok P, Minner S, Tachezy M, Borgmann K, Knecht R, Sauter G, Wilczak W, Blessmann M, Münscher A
PATHOL RES PRACT. 2014;210(10):649-655.

Serum EpCAM expression in pancreatic cancer
Gebauer F, Struck L, Tachezy M, Vashist Y, Wicklein D, Schumacher U, Izbicki J, Bockhorn M
ANTICANCER RES. 2014;34(9):4741-4746.

Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer
Gebauer F, Wicklein D, Horst J, Sundermann P, Maar H, Streichert T, Tachezy M, Izbicki J, Bockhorn M, Schumacher U
PLOS ONE. 2014;9(11):e113023.

ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer
Hofmann B, Stehr A, Dohrmann T, Güngör C, Herich L, Hiller J, Harder S, Ewald F, Gebauer F, Tachezy M, Precht C, Izbicki J, Bockhorn M, Wagener C, Wolters-Eisfeld G
CLIN CANCER RES. 2014;20(23):6117-26.

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)
Tachezy M, Gebauer F, Petersen C, Arnold D, Trepel M, Wegscheider K, Schafhausen P, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2014;14(1):411.

Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer
Tachezy M, Tiebel A, Gebauer F, Kutup A, Tharun L, Pantel K, Izbicki J, Vashist Y
HISTOPATHOLOGY. 2014;29(11):1467-1475.

Activated Leukocyte Cell Adhesion Molecule (CD166): An "Inert" Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki J, Bockhorn M
STEM CELLS. 2014;32(6):1429-1436.

CXCR7 expression in esophageal cancer
Tachezy M, Zander H, Gebauer F, Loga K, Pantel K, Izbicki J, Bockhorn M
J TRANSL MED. 2013;11:238.

Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula
Gebauer F, Kloth K, Tachezy M, Vashist Y, Cataldegirmen G, Izbicki J, Bockhorn M, Bockhorn M
ANN SURG. 2012;256(1):130-8.

Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival.
Harms-Effenberger K, Schröder C, Zu Eulenburg C, Reeh M, Tachezy M, Riethdorf S, Vashist Y, Izbicki J, Pantel K, Bockhorn M
INT J CANCER. 2012;131(4):475-483.

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
Roth C, Stückrath I, Pantel K, Izbicki J, Tachezy M, Schwarzenbach H
PLOS ONE. 2012;7(6):38248.

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
Tachezy M, Harms-Effenberger K, Zander H, Minner S, Gebauer F, Vashist Y, Sauter G, Pantel K, Izbicki J, Bockhorn M
INT J CANCER. 2012;131(2):396-405.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients
Tachezy M, Zander H, Gebauer F, Marx A, Kaifi J, Izbicki J, Bockhorn M
J SURG RES. 2012;177(1):e15-20.

ALCAM (CD166) expression and serum levels in pancreatic cancer
Tachezy M, Zander H, Marx A, Stahl P, Gebauer F, Izbicki J, Bockhorn M
PLOS ONE. 2012;7(6):e39018.

Management of the difficult duodenal stump in penetrating duodenal ulcer disease: a comparative analysis of duodenojejunostomy with "classical" stump closure (Nissen-Bsteh).
Vashist Y, Yekebas E, Gebauer F, Tachezy M, Bachmann K, König A, Kutup A, Izbicki J
LANGENBECK ARCH SURG. 2012;397(8):1243-1249.

Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Witzel I, Schröder C, Müller V, Zander H, Tachezy M, Henningsen M, Jänicke F, Milde-Langosch K
ONCOLOGY. 2012;82(6):305-312.

Multivisceral resections in pancreatic cancer: identification of risk factors
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-63.

Multivisceral resections in pancreatic cancer: identification of risk factors.
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-2763.

Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F, Tachezy M, Harms-Effenberger K, von Loga K, Zander H, Marx A, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG ONCOL. 2011;104(2):140-145.

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
Minner S, Kraetzig F, Tachezy M, Kilic E, Graefen M, Wilczak W, Bokemeyer C, Huland H, Sauter G, Schlomm T
HUM PATHOL. 2011;42(12):1946-1952.

High surgical morbidity following distal pancreatectomy: still an unsolved problem.
Reeh M, Nentwich M, Bogoevski D, König A, Gebauer F, Tachezy M, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(5):1110-1117.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
J GASTROINTEST SURG. 2011;15(5):829-35.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
J GASTROINTEST SURG. 2011;15(5):829-835.

ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M, Zander H, Marx A, Gebauer F, Rawnaq T, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG RES. 2011;170(2):226-232.

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer.
Vashist Y, Loos J, Dedow J, Tachezy M, Uzunoglu F, Kutup A, Yekebas E, Izbicki J
ANN SURG ONCOL. 2011;18(4):1130-1138.

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G, Bockhorn M, Schachner M, Izbicki J, Kaifi J
BMC CANCER. 2011;11:1-7.

Omental infarction in the postpartum period: a case report and a review of the literature.
Tachezy M, Grotelüschen R, Gebauer F, Marx A, Izbicki J, Kaifi J
J Med Case Rep. 2010;4:368.

Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M, Reichelt U, Melenberg T, Gebauer F, Izbicki J, Kaifi J
HISTOL HISTOPATHOL. 2010;25(10):1239-1246.

Abscess of adrenal gland caused by disseminated subacute Nocardia farcinica pneumonia. A case report and mini-review of the literature.
Tachezy M, Simon P, Ilchmann C, Vashist Y, Izbicki J, Gawad K
BMC INFECT DIS. 2009;9:194.

Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis
Graf K, Dietrich T, Tachezy M, Scholle F, Licha K, Stawowy P, Grafe M, Hauff P, Fleck E
MOL IMAGING. 2008;7(2):68-76.

ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions.
Thore D, Perlitz C, Licha K, Stawowy P, Atrott K, Tachezy M, Meyborg H, Stocker C, Gräfe M, Fleck E, Schirner M, Graf K
BASIC RES CARDIOL. 2007;102(4):298-307.

Letzte Aktualisierung aus dem FIS: 31.05.2020 - 00:43 Uhr